Mon, May 20, 2013, 9:33 PM EDT - U.S. Markets closed
you are viewing a single comment's thread.
i think the negativity is being a bit overdone.they had very little cash for a biotech running multiple trials. the dilution has hurt the stock and will forever hurt the stock. however, i see no way that heb is going to trade at $1.50.